What should you know about resveratrol and glioblastoma?

Resveratrol is a compound found in some plants and sold in supplement form. Laboratory findings can suggest effects on tumour cells, inflammation, or cell signalling, but results in a dish or animal model do not show that a supplement treats glioblastoma in a person. The dose, absorption, product quality, and interactions can differ substantially.

Glioblastoma is an aggressive brain tumour requiring care coordinated by neurosurgery, neuro-oncology, radiation oncology, and supportive teams. A supplement should be considered an additional exposure that may affect treatment, bleeding, the liver, or other medicines.

Tell your neuro-oncology team about resveratrol before taking it, including the brand, dose, and every other supplement or medicine. Do not stop prescribed treatment to try it. The usual care discussion may include brain tumour surgery, radiotherapy, chemotherapy, symptom control, and—when appropriate—a clinical trial with clear eligibility and monitoring.

If you are interested in complementary care, ask the pharmacist or oncology team to check interactions and whether the product could complicate surgery, blood tests, or treatment decisions. Choose a documented plan rather than relying on online claims.

Call emergency services for a first seizure, a seizure that does not stop, sudden weakness, new trouble speaking, severe confusion, or loss of consciousness. Contact the oncology team promptly for repeated vomiting, a rapidly worsening headache, new vision changes, or marked sleepiness. These symptoms need medical assessment and should not be managed with a supplement alone.

Ask whether resveratrol could interact with your medicines or planned operation, what evidence applies to your exact diagnosis, and whether a suitable clinical trial exists. Ask which symptoms should trigger an urgent call and how progress will be monitored.